News

Palantir Has a Hand in NIH’s Most Ambitious Health Initiative

By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

U.S. Federal

The Measured Listener

By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

U.S. States

These companies help parents try to pick their babies' traits. Experts are wary

By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

Genetic Selection

The start-ups dreaming of creating genetically modified babies

By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

U.S. Federal

N.C. House will Consider Eugenics Payouts Again

By Patrick Gannon, Star News Online | 12.13.2012
The N.C. House will again pursue legislation in 2013 to compensate state residents sterilized decades ago by a state-sanctioned board...
Bioethics

A DNA Database in the NHS: The End of Privacy?

By Helen Wallace, Public Service Europe | 12.12.2012
The government has announced plans to sequence the whole genomes of 100,000 patients in the NHS. This means every...
Human Rights

Why Your DNA is a Goldmine for Marketers

By Carolyn Abraham, The Globe and Mail | 12.12.2012

David Pike prefers hiking holidays over seaside lounging, and personalized ads over random promotions. “Show me the trails of Madeira,”...

Arts & Culture

Is California's Stem Cell Program Preparing to Waste $700,000?

By Michael Hiltzik, Los Angeles Times | 12.12.2012
If you're betting that the California stem cell agency will spurn key recommendations of a blue-ribbon review panel that criticized...
Biotech & Pharma

Genes, Patents, and Big Business: at 23andMe, are you the Customer or the Product?

By Adrianne Jeffries, The Verge | 12.12.2012
It’s been six years since DNA testing service 23andMe launched. In that time, about 180,000 people around the world have...
Patents & Other IP

Non-Invasive Prenatal Testing: Is This the Brave New World We Want?

By Alexandra Minna Stern, The Huffington Post | 12.11.2012
Over the past year, several companies have unveiled non-invasive prenatal tests designed to detect certain genetic conditions by analyzing fragments...
Genomics

Who's Mom? Legally, Biologically, it's no Easy Answer

By Martin E. Klimek, USA Today | 12.09.2012
In a classic 1960 children's book, a baby bird toddles up to one critter after another asking, "Are you my...
Assisted Reproduction

Genome Challenge Emerges in Society Sharing DNA Benefits

By John Lauerman, Bloomberg Businessweek | 12.09.2012

Sharing the benefits of DNA science across social and class lines is one of the next big challenges facing genome...

Bioethics